Heterocyclic compound and organic electroluminescence device including the same

US10741774B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10741774-B2
Application numberUS-201715839740-A
CountryUS
Kind codeB2
Filing dateDec 12, 2017
Priority dateJul 4, 2017
Publication dateAug 11, 2020
Grant dateAug 11, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A heterocyclic compound represented by Formula 1 and an organic electroluminescence device including the same in an emission layer. In Formula 1, Z is represented by Formula 2-1 or 2-2. In Formula 2-2, X 1 to X 3 are each independently CR 10 or N, and at least one of X 1 to X 3 is N.

First claim

Opening claim text (preview).

What is claimed is: 1. A heterocyclic compound represented by Formula 1, wherein an absolute value of a difference between a singlet energy level and a triplet energy level of the heterocyclic compound is about 0.2 eV or less: wherein, in Formula 1, R 1 to R 6 are each independently a hydrogen atom, a deuterium atom, a halogen atom, a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms for forming a ring, or a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms for forming a ring, L is a substituted or unsubstituted arylene group having 6 to 30 carbon atoms for forming a ring, or a substituted or unsubstituted heteroarylene group having 2 to 30 carbon atoms for forming a ring, a, b, c, d and e are each independently an integer of 0 to 4, f is an integer of 0 to 3, n is 0 or 1, and Z is represented by Formula 2-1 or Formula 2-2: wherein, in Formula 2-1, g is 1 or 2, when g is 1, h is an integer of 0 to 4, and when g is 2, h is an integer of 0 to 3, and R 7 is a hydrogen atom, a deuterium atom, a halogen atom, a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms for forming a ring, or a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms for forming a ring, wherein, in Formula 2-2, X 1 to X 3 are each independently CR 10 or N, at least one of X 1 to X 3 is N, and R 8 to R 10 are each independently a hydrogen atom, a deuterium atom, a halogen atom, a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms for forming a ring, or a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms for forming a ring, wherein when Z is represented by Formula 2-1, n is 1. 2. The heterocyclic compound of claim 1 , wherein Z is represented by one of Formulae 3-1 to 3-9: 3. A heterocyclic compound represented by Formula 1, wherein an absolute value of a difference between a singlet energy level and a triplet energy level of the heterocyclic compound is about 0.2 eV or less: wherein, in Formula 1, R 1 to R 6 are each independently a hydrogen atom, a deuterium atom, a halogen atom, a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms for forming a ring, or a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms for forming a ring, L is a substituted or unsubstituted arylene group having 6 to 30 carbon atoms for forming a ring, or a substituted or unsubstituted heteroarylene group having 2 to 30 carbon atoms for forming a ring, a, b, c, d and e are each independently an integer of 0 to 4, f is an integer of 0 to 3, n is 0 or 1, and Z is represented by Formula 2-1 or Formula 2-2: wherein, in Formula 2-1, p is 1 or 2, when g is 1, h is an integer of 0 to 4, and when g is 2, h is an integer of 0 to 3, and R 7 is a hydrogen atom, a deuterium atom, a halogen atom, a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms for forming a ring, or a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms for forming a ring, wherein, in Formula 2-2, X 1 to X 3 are each independently CR 10 or N, at least one of X 1 to X 3 is N, and R 8 to R 10 are each independently a hydrogen atom, a deuterium atom, a halogen atom, a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms for forming a ring, or a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms for forming a ring, wherein Z is represented by Formula 2-2-1: wherein, in Formula 2-2-1, W 1 to W 5 are each independently CH or N, and X 1 to X 3 are the same as defined above. 4. The heterocyclic compound of claim 3 , wherein a total number of N in W 1 to W 5 is 0 or 1. 5. The heterocyclic compound of claim 1 , wherein L is a substituted or unsubstituted phenylene group. 6. The heterocyclic compound of claim 1 , wherein at least one of R 1 , R 2 , R 4 , and R 5 is a substituted or unsubstituted phenyl group, or a substituted or unsubstituted carbazole group. 7. The heterocyclic compound of claim 6 , wherein at least one of R 1 , R 2 , R 4 , and R 5 is represented by one of following structures: 8. The heterocyclic compound of claim 1 , wherein a+b+d+e is 0, 1 or 2. 9. The heterocyclic compound of claim 1 , wherein the heterocyclic compound represented by Formula 1 is one selected from compounds represented in Compound Group 1: 10. An organic electroluminescence device, comprising: a first electrode; a hole transport region on the first electrode; an emission layer on the hole transport region; an electron transport region on the emission layer; and a second electrode on the electron transport region, wherein the emission layer comprises a heterocyclic compound represented by Formula 1, an absolute value of a difference between a singlet energy level and a tri

Assignees

Inventors

Classifications

  • containing three or more hetero rings · CPC title

  • C07D401/14Primary

    containing three or more hetero rings · CPC title

  • with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system · CPC title

  • comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole · CPC title

  • characterised by the electroluminescent [EL] layers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10741774B2 cover?
A heterocyclic compound represented by Formula 1 and an organic electroluminescence device including the same in an emission layer. In Formula 1, Z is represented by Formula 2-1 or 2-2. In Formula 2-2, X 1 to X 3…
Who is the assignee on this patent?
Samsung Display Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D401/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).